Navigation Links
CooperVision Adds Global Professional Relations Role; Richard Clompus Joins Company as Vice President
Date:1/18/2010

PLEASANTON, Calif., Jan. 18 /PRNewswire/ -- CooperVision today announced that Richard Clompus, OD, FAAO, has joined the company as vice president, global professional relations within the Global Commercial Strategy team. Dr. Clompus will support clinical studies, education, and professional affairs on a worldwide basis in order to further establish CooperVision's position in the global contact lens industry.

"Richard brings a wealth of experience and technical expertise to this role," said Jeffrey A. McLean, executive vice president, Global Commercial Strategy, CooperVision. "We look forward to his contribution as we continue to develop our professional relations strategy, clinical programs, and enhance the overall experience of our customers."

Dr. Clompus most recently served as director of The Vision Care Institute, LLC, supporting student and doctor education in the U.S., Canada, and Puerto Rico. Prior to that, he was part of Johnson & Johnson Vision Care where he held leadership positions within The Spectacle Lens Group and Vistakon. He is a member of the American Optometric Association, charter member of the AOA Contact Lens Section, and Fellow of the American Academy of Optometry.

Dr. Clompus was also in private practice for 20 years, establishing an innovative optometric practice in West Chester, Pa., providing multidisciplinary eye care and contact lens specialty services. He has exceptional expertise in the use of multimedia technologies for presentations and training, published many journal articles, and is a contributing author to several publications. Dr. Clompus graduated from the Pennsylvania College of Optometry and completed a family practice residency at the University of Alabama School of Optometry in Birmingham. 

He and his family will be relocating to CooperVision's global headquarters in Pleasanton, Calif.  

About CooperVision

CooperVision, a unit of The Cooper Companies, Inc. (NYSE: COO), is one of the world's leading manufacturers of soft contact lenses. Dedicated to enhancing the contact lens experience for practitioners and patients, CooperVision specializes in lenses for astigmatism, presbyopia, and ocular dryness. CooperVision manufactures a full array of monthly, two-week, and daily disposable contact lenses featuring advanced materials and optics. For more information, visit www.coopervision.com.

SOURCE CooperVision

RELATED LINKS
http://www.coopervision.com

'/>"/>

SOURCE CooperVision
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Putney to Present at the Jefferies 2010 Global Healthcare Services Conference
2. MarketsandMarkets: Global Probiotics Market Worth US$32.6 Billion by 2014
3. WellTek Subsidiary MedX Limited Increases Presence in Global Market
4. Sanofi Pasteur Global Dengue Vaccine Clinical Program Expanded in Latin America
5. Reportlinker Adds Bulk Paclitaxel - A Global Update of Market Trends & Opportunities
6. Reportlinker Adds Cardiac Biomarkers - A Global Market Perspective
7. Reportlinker Adds Radiation Therapy Equipment - A Global Market Review
8. Reportlinker Adds Ion-Selective Clinical Lab Analyzers - Global Market Opportunities
9. Reportlinker Adds Training Manikins - Global Trends
10. Top 5 Global Spinal Implant Companies Maintaining Position but Competition Rising Rapidly
11. Global Announces Contract To Acquire New Business
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/9/2017)... , June 9, 2017 AirXpanders, Inc. ... focused on the design, manufacture, sale and distribution of ... on the progress of its commercial roll-out in ... available in more than one hundred (100) medical institutions ... AeroForm offers a needle-free alternative for women who ...
(Date:6/7/2017)... -- Endo International plc (NASDAQ: ENDP ) ... Joseph R. Goodwin , U.S. District Court Judge for ... , entered a case management order in MDL 2325, ... Litigation (the "MDL") that includes a provision requiring plaintiffs ... on specific causation within one hundred twenty (120) days ...
(Date:6/3/2017)... June 3, 2017  Eli Lilly and Company ... results from the Phase 3 MONARCH 2 study ... 6 inhibitor, in combination with fulvestrant, significantly improved ... alone in women with hormone-receptor-positive (HR+), human epidermal ... who have relapsed or progressed after endocrine therapy ...
Breaking Medicine Technology:
(Date:6/20/2017)... ... ... As a leading dental practice, Wall Centre Dental supports Stroke Awareness Month ... bleeding gums in Vancouver, BC, may be developing gingivitis, the first stage of ... and diabetes. Drs. Parviz Roshan, Siamak Tehrani and Milton Reskovich offer laser gum therapy ...
(Date:6/20/2017)... ... June 20, 2017 , ... This year, participants in the ... finding product improvements that could reduce the occurrence of unplanned extubations (UEs). ... breathing or to provide medication. Sometimes, patient movement can cause unplanned extubations which ...
(Date:6/20/2017)... ... June 20, 2017 , ... Uniform Advantage ... featuring seven new products designed to create tailored looks and athleisure-inspired outfits. UA Flex ... cotton easy care stretch twill. , With trendy looks hitting the medical community, UA ...
(Date:6/20/2017)... ... , ... John D'Eri, CEO of Rising Tide Car Wash , will ... during the Autism Society of America 's 49th annual conference to be held ... (DJFF) was founded in 2002 as the nation's first autism organization focused exclusively ...
(Date:6/20/2017)... ... June 20, 2017 , ... International water ... The Sharon Kleyne Hour Power of Water, Global Climate Change and Your Health ... world’s water crisis and how it affects the human eyes. , According ...
Breaking Medicine News(10 mins):